Open AccessActivity of ceftazidime (GR 20263) against nosocomially important pathogens
Author(s) -
J M Hamilton-Miller,
W. Brumfitt
Publication year - 1981
Publication title -
antimicrobial agents and chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.07
H-Index - 259
eISSN - 1070-6283
pISSN - 0066-4804
DOI - 10.1128/aac.19.6.1067
Subject(s) - ceftazidime , cefuroxime , gentamicin , antibiotics , microbiology and biotechnology , cephalosporin , bacteria , antibacterial agent , gram negative bacteria , medicine , biology , pseudomonas aeruginosa , escherichia coli , biochemistry , gene , genetics
Ceftazidime was considerably more active than cefuroxime against 180 strains of resistant species of nosocomial gram-negative bacteria. In terms of antibacterial spectrum and intrinsic activity, ceftazidime is an improvement upon existing beta-lactam antibiotics in clinical use and can be regarded as a possible alternative to gentamicin.